Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Carboplatin | Carboplatin is a DNA synthesis inhibitor by binding to DNA and interfering with the cell's repair mechanism. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 41575-94-4. Pack Sizes: 1 g. Product ID: B2692-293445. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Carboplatin (Diammine (1, 1-cyclobutane dicarboxylato) platinum (II) ) | 100mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C6H12N2O4Pt. CAS No. 41575-94-4. Prepack ID : 56513477-100mg. Molecular Weight : 371.25. |  |
| Carboplatin (Diammine (1, 1-cyclobutane dicarboxylato) platinum (II) ) | 250mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C6H12N2O4Pt. CAS No. 41575-94-4. Prepack ID : 56513477-250mg. Molecular Weight : 371.25. | |
| Carboplatin (Diammine (1, 1-cyclobutane dicarboxylato) platinum (II) ) | 25mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C6H12N2O4Pt. CAS No. 41575-94-4. Prepack ID : 56513477-25mg. Molecular Weight : 371.25. | |
| Carboplatin Impurities | Carboplatin Impurities, existing as variant forms within carboplatin preparations, play an essential role in oncology therapeutic quality control and investigative research. They are scrutinized to affirm the safety and effectiveness of carboplatin, a chemotherapy agent extensively employed against ovarian, lung, and diverse cancer types, elucidating their impact on pharmaceutical stability. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML 385 | ML 385 is a novel and specific inhibitor of nuclear factor erythroid 2-related factor 2 (Nrf2; IC50 = 1.9 μM). ML 385 blocks NRF2 transcriptional activity, and enhances the efficacy of carboplatin as well as other chemotherapeutic drugs in lung cancer cells (NSCLC). Group: Pharmaceutical. CAS No. 846557-71-9. Pack Sizes: 100 mg. Product ID: B0084-007736. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Satraplatin | Satraplatin, also known as JM216, is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. It has not yet received approval from the U.S. Food and Drug Administration. First mentioned in the medical literature in 1993, satraplatin is the first orally active platinum-based chemotherapeutic drug; other available platinum analogues-cisplatin, carboplatin, and oxaliplatin-must be given intravenously. It is made available in the United States jointly by Spectrum Pharmaceuticals and GPC Biotech under the name SPERA (Satraplatin Expanded Rapid Access). The drug has also been used in the treatment of lung and ovarian cancers. The proposed mode of action is that the compound binds to the DNA of cancer cells rendering them incapable of dividing. Group: Pharmaceutical. CAS No. 129580-63-8. Pack Sizes: 50 mg. Product ID: B0084-056858. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
